Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

GENETIC TECHNOLOGIES LIMITED Director's Dealing 2006

Nov 12, 2006

65022_rns_2006-11-12_38c8346a-8e10-477b-b093-da68a1018160.pdf

Director's Dealing

Open in viewer

Opens in your device viewer

Appendix 3Y

Rule 3.19A.2

Change of Director's Interest Notice

Information or documents not available now must be given to ASX as soon as available. Information and documents given to ASX become ASX's property and may be made public.

Introduced 30/9/2001.

Name of entity: Genetic Technologies Limited
ABN: 17 009 212 328

We (the entity) give ASX the following information under listing rule 3.19A.2 and as agent for the director for the purposes of section 205G of the Corporations Act.

Name of Director Dr. Mervyn Jacobson
Date of last notice 8 November 2006

Part 1 - Change of director's relevant interests in securities

In the case of a trust, this includes interests in the trust made available by the responsible entity of the trust

Note: In the case of a company, interests which come within paragraph (i) of the definition of "notifiable interest of a director" should be disclosed in this part.

Direct or indirect interest Direct and indirect
Nature of indirect interest
(including registered holder)
Note: Provide details of the circumstances giving rise to the relevant
interest.
Dr. Jacobson controls Mervyn Jacobson ApS
which holds 49,000,000 shares
Dr. Jacobson is a beneficiary of the Jacobson
Global Trust, which holds 98,000,000 shares
through JGT ApS
Dr. Jacobson holds a relevant interest in XY, Inc.
Dates of change 9 November 2006 and 10 November 2006
No. of securities held prior to change JGT ApS - 98,000,000 shares
Mervyn Jacobson ApS - 49,000,000 shares
$XY$ , Inc. $-3,278,200$ shares
Direct personal $-3,931,900$ shares
Direct personal – 2,000,000 options $\omega$ \$0.61
Class Fully paid ordinary shares and unlisted options
Number acquired 47,500 shares by XY, Inc.
Number disposed Not applicable
Value/Consideration
Note: If consideration is non-cash, provide details and estimated
valuation
In respect of 10,000 shares - \$3,600.00
In respect of 37,500 shares - \$13,567.50

+ See chapter 19 for defined terms.

No. of securities held after change JGT $ApS - 98,000,000$ shares
Mervyn Jacobson ApS - 49,000,000 shares
$XY, Inc. - 3,325,700 shares$
Direct personal $-3,931,900$ shares
Direct personal – 2,000,000 options $\omega$ \$0.61
Nature of change
Example: on-market trade, off-market trade, exercise of options,
issue of securities under dividend reinvestment plan, participation in
buy-back
Purchase of 47,500 ordinary shares by XY, Inc.
$\omega$ an average of \$0.361 per share

Part 2 - Change of director's interests in contracts

Note: In the case of a company, interests which come within paragraph (ii) of the definition of "notiliable interest of a director" should be disclosed in this part.

Detail of contract
Nature of interest
Name of registered holder
(if issued securities)
Date of change
No. and class of securities to which
interest related prior to change
Note: Details are only required for a contract in relation
to which the interest has changed
Interest acquired
Interest disposed
Value/Consideration
Note: If consideration is non-cash, provide details and
an estimated valuation
Interest after change

Dated: 13 November 2006

$+$ See chapter 19 for defined terms.